01—Abstract
Summary
Summary of the 8-K filed December 6, 2023. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has filed an 8-K detailing an amendment to its employment agreement with Chairman and CEO Terrence A.
Duffy. The amendment, effective December 6, 2023, extends Mr. Duffy's current term from December 31, 2024, to December 31, 2025, with substantially the same principal terms as his existing agreement. The Board of Directors believes Mr. Duffy's continued leadership is crucial for executing the company's strategy and driving long-term shareholder value, citing his deep industry knowledge and strategic vision.
Importantly, this extension does not alter Mr. Duffy's current base salary, target bonus, or target equity grant value. The agreement outlines specific provisions regarding a bonus opportunity for the 2025 plan year and accelerated vesting of outstanding equity awards upon employment completion by December 31, 2025, contingent on a general release. This move signals stability in leadership at a critical juncture for CME Group.
02—Key points
Key Highlights
- CEO Terrence A. Duffy's employment agreement extended through December 31, 2025.
- The extension aims to ensure continuity of leadership and strategic direction.
- No changes were made to Mr. Duffy's base salary, target bonus, or target equity grant values.
- The amended agreement includes provisions for a 2025 bonus and accelerated equity vesting upon completion of the term.
- Equity award vesting is contingent on actual company performance and execution of a general release.
- The Board reaffirms confidence in Mr. Duffy's leadership for long-term shareholder value creation.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this filing is to announce the amendment and restatement of the employment agreement for CME Group's Chairman and CEO, Terrence A. Duffy, extending his term of employment.
Does this extension involve any immediate change to Mr. Duffy's compensation?
No, the filing explicitly states that no changes were made to Mr. Duffy's minimum annual base salary, target bonus opportunity, or target grant date value opportunity under the amended agreement.
What are the key terms regarding compensation upon the end of the extended term?
If Mr. Duffy is employed through December 31, 2025, he will be entitled to a bonus opportunity for the 2025 plan year and all outstanding unvested time-vesting equity awards will vest. Performance-based equity awards will vest or be forfeited based on actual company performance over the full term. Both the bonus and vesting are subject to his timely execution of a general release.
Why did the Board decide to extend Mr. Duffy's contract?
The Board believes Mr. Duffy's strategic direction, innovative leadership, and in-depth industry knowledge are essential for the company's continued success and for executing its strategy to create long-term shareholder value.
04—Continue